Your browser is no longer supported. Please, upgrade your browser.
Settings
CRY CryoLife, Inc. daily Stock Chart
CRY [NYSE]
CryoLife, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own4.10% Shs Outstand37.52M Perf Week-1.71%
Market Cap760.93M Forward P/E113.11 EPS next Y0.18 Insider Trans-0.62% Shs Float36.41M Perf Month10.58%
Income-11.20M PEG- EPS next Q-0.03 Inst Own83.50% Short Float10.48% Perf Quarter-6.55%
Sales257.80M P/S2.95 EPS this Y149.90% Inst Trans0.58% Short Ratio10.48 Perf Half Y-24.81%
Book/sh7.90 P/B2.62 EPS next Y263.60% ROA-1.80% Target Price26.30 Perf Year-20.32%
Cash/sh3.42 P/C6.06 EPS next 5Y2.00% ROE-3.90% 52W Range12.63 - 31.77 Perf YTD-23.59%
Dividend- P/FCF161.90 EPS past 5Y-30.20% ROI3.30% 52W High-34.84% Beta1.33
Dividend %- Quick Ratio4.60 Sales past 5Y13.80% Gross Margin66.70% 52W Low63.90% ATR0.81
Employees1200 Current Ratio5.90 Sales Q/Q-24.30% Oper. Margin2.00% RSI (14)52.37 Volatility3.77% 3.91%
OptionableYes Debt/Eq1.00 EPS Q/Q-231.30% Profit Margin-4.30% Rel Volume0.33 Prev Close21.31
ShortableYes LT Debt/Eq0.99 EarningsJul 30 AMC Payout- Avg Volume364.27K Price20.70
Recom1.80 SMA204.96% SMA502.78% SMA200-10.43% Volume121,372 Change-2.86%
Feb-14-20Downgrade First Analysis Sec Strong Buy → Outperform
Feb-14-20Downgrade Canaccord Genuity Buy → Hold $32 → $29
Jan-29-20Reiterated Needham Buy $30 → $38
Dec-11-19Upgrade Needham Hold → Buy
Oct-22-19Initiated Oppenheimer Outperform $34
Feb-28-19Initiated Needham Hold
Feb-17-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-09-17Initiated Northland Capital Outperform $23.50
Jun-15-16Initiated Lake Street Buy $15
Apr-28-16Downgrade Ladenburg Thalmann Buy → Neutral
Apr-21-16Resumed Piper Jaffray Overweight
Apr-13-16Initiated Canaccord Genuity Buy $14
Aug-06-12Downgrade The Benchmark Company Buy → Hold
Apr-24-12Initiated Ladenburg Thalmann Buy $7.75
Jul-29-11Upgrade The Benchmark Company Hold → Buy $6.50
Apr-29-11Downgrade The Benchmark Company Buy → Hold $7 → $6.50
Jul-23-10Initiated The Benchmark Company Buy $8
Aug-01-08Reiterated Roth Capital Buy $14 → $15
Aug-01-08Reiterated Jesup & Lamont Buy $14 → $16.50
May-15-08Reiterated Roth Capital Buy $12 → $14
Aug-06-20 08:35AM  
Jul-31-20 10:47AM  
Jul-30-20 07:40PM  
04:05PM  
Jul-23-20 12:32PM  
Jul-21-20 05:00PM  
Jun-19-20 07:05AM  
Jun-18-20 03:07PM  
07:14AM  
07:05AM  
Jun-14-20 08:33PM  
May-08-20 01:10AM  
May-01-20 02:31PM  
Apr-23-20 12:32PM  
Apr-16-20 04:05PM  
Apr-02-20 01:00PM  
07:15AM  
Apr-01-20 04:01PM  
Mar-04-20 04:05PM  
Mar-03-20 05:19PM  
Mar-02-20 08:59AM  
Feb-13-20 06:05PM  
04:05PM  
Feb-06-20 12:31PM  
Jan-30-20 08:34AM  
Jan-21-20 06:06AM  
Jan-17-20 12:02PM  
Jan-16-20 08:37AM  
Dec-23-19 08:30AM  
Dec-19-19 08:30AM  
Dec-16-19 06:08AM  
05:59AM  
Dec-02-19 08:02AM  
08:00AM  
Nov-27-19 07:00AM  
Nov-10-19 08:40AM  
Nov-05-19 09:40AM  
Oct-30-19 07:35PM  
04:05PM  
Oct-28-19 05:07PM  
Oct-23-19 10:33AM  
Oct-16-19 04:35PM  
Oct-15-19 08:22AM  
Sep-18-19 08:34AM  
Sep-15-19 10:21AM  
Sep-13-19 09:07AM  
Sep-11-19 04:03PM  
Aug-29-19 08:34AM  
07:00AM  
Aug-16-19 02:28PM  
Aug-05-19 08:47AM  
Aug-03-19 09:25AM  
Aug-02-19 10:48AM  
Jul-31-19 12:24AM  
Jul-30-19 07:45PM  
04:05PM  
02:30PM  
Jul-25-19 08:34AM  
Jul-23-19 10:32AM  
Jul-17-19 08:34AM  
Jul-12-19 01:18PM  
Jun-28-19 06:54PM  
May-06-19 02:43PM  
May-03-19 11:16AM  
Apr-30-19 11:04PM  
05:19PM  
04:05PM  
Apr-23-19 10:32AM  
Apr-17-19 05:05PM  
Apr-03-19 08:30AM  
Mar-26-19 09:36AM  
Mar-05-19 05:00PM  
Feb-20-19 07:27PM  
Feb-18-19 08:30AM  
Feb-14-19 01:10PM  
12:27PM  
Feb-13-19 09:00PM  
07:59PM  
07:30PM  
Feb-06-19 10:30AM  
Feb-01-19 05:00PM  
Dec-19-18 08:00AM  
Nov-13-18 08:25AM  
Nov-09-18 09:27PM  
Oct-31-18 07:15PM  
06:09PM  
05:04PM  
07:51AM  
Oct-15-18 05:00PM  
Sep-24-18 06:08PM  
Sep-18-18 05:00PM  
10:00AM  
Aug-21-18 01:46AM  
Aug-07-18 06:30AM  
Aug-06-18 06:55PM  
05:52PM  
05:30PM  
Jul-26-18 08:30AM  
Jul-18-18 08:30AM  
Jun-21-18 02:45PM  
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products, a range of stent graft systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G, a stent graft system for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers vascular preservation services; synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products, such as YAG laser consoles, related service and maintenance, and single-use, fiber-optic handpieces; and CryoVein femoral vein and CryoArtery femoral artery vascular preservation services for vascular access. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Horton AmyVP, Chief Accounting OfficerMay 28Sale23.813,00071,41599,642May 29 08:06 AM
McCall Ronald DDirectorMay 05Sale22.821,71939,219127,766May 07 05:14 PM
McCall Ronald DDirectorFeb 24Sale26.054,734123,340127,865Feb 25 04:38 PM
Holloway Jean FVP, General CounselJan 21Option Exercise9.648,45881,53567,322Jan 23 04:13 PM
Holloway Jean FVP, General CounselJan 21Sale30.008,458253,74458,864Jan 23 04:13 PM
Holloway Jean FVP, General CounselJan 16Option Exercise9.641951,88059,059Jan 21 04:28 PM
Holloway Jean FVP, General CounselJan 16Sale30.001955,85058,864Jan 21 04:28 PM
Holloway Jean FVP, General CounselDec 12Option Exercise10.243,00030,72061,864Dec 13 04:16 PM
Holloway Jean FVP, General CounselDec 12Sale26.003,00078,00058,864Dec 13 04:16 PM
Capps Scott BVP, Clinical ResearchNov 26Option Exercise6.1210,00061,200151,079Nov 27 04:13 PM
Capps Scott BVP, Clinical ResearchNov 26Sale24.937,184179,108143,895Nov 27 04:13 PM
McCall Ronald DDirectorNov 19Sale24.644,00098,565132,599Nov 19 04:43 PM
Mackin James PPresident & CEONov 13Buy23.475,000117,355225,731Nov 13 04:14 PM